Skip to main content
SpringerLink
Log in
Book cover

Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome pp 169–186Cite as

Macrovascular Disease

  • Chapter
  • First Online:

  • 3224 Accesses

Part of the book series: Current Clinical Practice ((CCP))

Abstract

Type-2 diabetes, by virtue of its predisposition to generalized arteriosclerotic vascular disease, inflammatory milieu, and thrombogenesis is truly a vasculopathic state.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Deckert T, et al. Implications for micro-and macrovascular disease. Diabetes Care 1992;15:1181–1191.

    Article  PubMed  CAS  Google Scholar 

  2. Greenfield S, Billimek J, Pellegrini F, Franciosi M, DeBerardis G. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes. Ann Intern Med 2009;151:854–860.

    Article  PubMed  Google Scholar 

  3. Haffner SM, Lehto S, et al. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229–234.

    Article  PubMed  CAS  Google Scholar 

  4. Kelly TN, Bazzano LA, Fonseca VA, Thethi TK, Reynolds K, He J. Systematic review: glucose control and cardiovascular disease in type-2 diabetes. Ann Intern Med 2009;151:394–403.

    Article  PubMed  Google Scholar 

  5. Stamler J, Caccaro O, Neaton JD, Wentrworth D. Diavetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial (MRFIT). Diabetes Care 1993;16:434–444.

    Article  PubMed  CAS  Google Scholar 

  6. Gilpin E, Ricou F, et al. Factors associated with recurrent myocardial infarction within one year after acute myocardial infarction. Am Heart J 1991;121:457–463.

    Article  PubMed  CAS  Google Scholar 

  7. Herlitz J, Malmberg K, et al. Mortality and morbidity during a five year follow up of diabetics with myocardial infarction. Acta Med Scand 1988;224:31–38.

    Article  PubMed  CAS  Google Scholar 

  8. Eschwege E, Richard JL, Thibult N. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study. Horn Metab Res Suppl 1985;15:41–46.

    CAS  Google Scholar 

  9. Hansson L, Zanchetti A, Carruthers SG. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755–1762.

    Article  PubMed  CAS  Google Scholar 

  10. Lehto, S, Pyorala K, Miettinen H, et al. Myocardial infarct size and mortality in patients with non-insulin dependent diabetes mellitus. J Intern Med 1994;236:291–297.

    Article  PubMed  CAS  Google Scholar 

  11. Uusitupa M, et al. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 diabetes. Diabetolologia 1985;28:653–659.

    Article  CAS  Google Scholar 

  12. Fuller JH, et al. Coronary heart disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 1980;1:1373–1376.

    Article  PubMed  CAS  Google Scholar 

  13. Jarrett RJ, et al. Diabetes mellitus and cardiovascular disease – putative association via common antecedents. Diabetologia 1988;31:737–740.

    Article  PubMed  CAS  Google Scholar 

  14. Levine GN, Jacobs AK, et al. Impact of diabetes mellitus on percutaneous revascularization CAVEAT-I Investigators. Coronary Angioplasty versus Excisional Atherectomy Trial. Am J Cardiol 1997;79:748–755.

    Article  PubMed  CAS  Google Scholar 

  15. Creager MA. Results of the CAPRIE trial: efficacy and safety of clopidogrel. Vasc Med 1998;3(3):257–260.

    PubMed  CAS  Google Scholar 

  16. Van Belle E, Bauters C, et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997;96:1454–1460.

    Article  PubMed  Google Scholar 

  17. Taylor GJ, Moses HW, et al. Six year survival after coronary thrombolysis and early revascularization for acute myocardial infarction. Am J Cardiol 1992;70:26–30.

    Article  PubMed  CAS  Google Scholar 

  18. Elliot WJ, Meyer PM. Incident diabetesin clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007;369(9557):201–207.

    Article  Google Scholar 

  19. Zuanetti G, Latini R, Maggioni AP, Franzosi M, Santoro L, Tognoni G. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction. Circulation 1997;96:4239–4245.

    Article  PubMed  CAS  Google Scholar 

  20. Patti G, Nusca A, DiSciascio G. Meta-analysis comparison (Nine Trilas) of outcomes with drug eluting stents versus bare metal stents in patients with diabetes mellitus. Am J Cardiol 2008;102:1328–1334.

    Article  PubMed  CAS  Google Scholar 

  21. FRISC II Investigators. Long term low molecular mass heparin in unstable angina: FRISC-II multicenter study. Lancet 1999;354:701–707.

    Google Scholar 

  22. Ridker P, Cushman M, Stampfer M, Tracy R. Inflammation, aspirin and risk of cardiovascular disease in healthy men. N Engl J Med 1997;337(5):356.

    Google Scholar 

  23. Hiatt WR. New treatment options in intermittent claudication. In J Clin Pract Suppl 2001;119:20–27.

    CAS  Google Scholar 

  24. Criqui MH, Langer RD, Fronek A. Mortality over a period of 10 years in patients with peripheral vascular disease. N Engl J Med 1992;326:381–386.

    Article  PubMed  CAS  Google Scholar 

  25. Jensen-Urstad KJ, Reichard PG, et al. Early atherosclerosis is retarded by improved long term blood glucose control in patients with IDDM. Diabetes 1996;45:1253–1258.

    Article  PubMed  CAS  Google Scholar 

  26. Donnelly R. Assessment and management of intermittent claudication: importance of secondary prevention. Int J Clin Pract Suppl 2001;119:2–9.

    PubMed  Google Scholar 

  27. McDermott MM, Guralnik JM, Greenland P. Statin use and leg functioning in patients with and without lower extremity peripheral arterial disease. Circulation 2003;107:757–761.

    Article  PubMed  CAS  Google Scholar 

  28. Hiatt WR. New treatment options in intermittent claudication: the US experience. Int J Clin Pract Suppl 2001:119:20–37.

    PubMed  CAS  Google Scholar 

  29. North American Symptomatic Carotid Endarterecdtomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med 1991;325:445–453.

    Article  Google Scholar 

  30. Rothwell PM, Gutnikoff SA, Warlow CP. Reanalysis of the European Carotid Surgery Trial. Stroke 2003;34:514.

    Article  PubMed  CAS  Google Scholar 

  31. Sauve JS, Thorpe KE, Sackett DL. The North American Symptomatic Carotid Endarterectomy Trial. Can bruits distinguish high grade from moderate symptomatic carotid Stenosis? Ann Intern Med 1994;120:633–637.

    Article  PubMed  CAS  Google Scholar 

  32. Vijan S, Hayward RA. Pharmacologic lipid lowering therapy in type-2 diabetes mellitus. Ann Intern Med 2004;140:650–658.

    Article  PubMed  CAS  Google Scholar 

  33. Libby P, Plutzky J. Diabetic macrovascular disease: the glucose paradox. Circulation 2002;106:2760–2763.

    Article  PubMed  Google Scholar 

  34. Dahlof B, Kjeldsen RB, Julius SE, Beevers S, de Faire U. Cardiovascular mortality and morbidity in the losartan intervention for endpoint reduction in hypertension study (LIFE). Lancet 2002;359(9311):995–1003.

    Article  PubMed  CAS  Google Scholar 

  35. Vinik A, Vinik E. Prevention of the complications of diabetes. Am J Manag Care 2003;9(3):S63–S77.

    Google Scholar 

Supplementary Readings

  • Agewall S, Fagerberg B, et al. Carotid artery wall intima media thickness is associated with insulin mediated glucose disposal in men at high and low coronary risk. Stroke 1995;26:956–960.

    Article  PubMed  CAS  Google Scholar 

  • American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998;21:1551–1559.

    Article  Google Scholar 

  • Aronson D, Bloomgarden Z, et al. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996;27:528–535.

    Article  PubMed  CAS  Google Scholar 

  • Brownlee M, et al. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315–1321.

    Article  PubMed  CAS  Google Scholar 

  • Carrozza J, Kuntz R, et al. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993;118:344–349.

    Article  PubMed  Google Scholar 

  • Clark RS, English M, et al. Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction. BMJ 1985;291:303–305.

    Article  PubMed  CAS  Google Scholar 

  • Fava S, Azzopardi J, et al. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 1993;16:1615–1618.

    Article  PubMed  CAS  Google Scholar 

  • Gum P, O’Keefe JJ, et al. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation 1997;96(9 Suppl):II7–II10.

    Google Scholar 

  • Kornowski R, Mintz GS, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. Circulation 1997;95:1366–1369.

    Article  PubMed  CAS  Google Scholar 

  • Krolewski AS, et al. Magnitude and determinants of coronary artery disease in juvenile onset, insulin dependent diabetes mellitus. Am J Cardiol 1987;59:750–755.

    Article  PubMed  CAS  Google Scholar 

  • Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993;71:26B–31B.

    Article  PubMed  CAS  Google Scholar 

  • Sobel BE. Acceleration of restenosis by diabetes. Circulation 2001;103:1185–1187.

    Article  PubMed  CAS  Google Scholar 

  • Soler NG, Bennett MA, et al. Myocardial infarction in diabetics. Q J Med 1975;44:125–132.

    PubMed  CAS  Google Scholar 

  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977–996.

    Article  Google Scholar 

  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837–853.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Pennsylvania Health System Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

    Ronald A. Codario MD, FACP (Clinical Instructor in Medicine)

Authors
  1. Ronald A. Codario MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Diplomate American Board of Internal Medicine

Diplomate American Board of Clinical Lipidology

Diplomate American Board of Vascular Medicine

Clinical Hypertension Specialist (American Society of Hypertension Certified)

Vascular Ultrasound (American Registry of Diagnostic Sonography Certified)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Codario, R.A. (2011). Macrovascular Disease. In: Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-441-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-441-8_9

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-440-1

  • Online ISBN: 978-1-60327-441-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation